AGIO Stock Summary

• Of note is the ratio of Agios Pharmaceuticals Inc's sales and general administrative expense to its total operating expenses; merely 12.55% of US stocks have a lower such ratio.
• With a price/sales ratio of 17.8, Agios Pharmaceuticals Inc has a higher such ratio than 94.06% of stocks in our set.
• As for revenue growth, note that AGIO's revenue has grown 51.65% over the past 12 months; that beats the revenue growth of 89.77% of US companies in our set.
• If you're looking for stocks that are quantitatively similar to Agios Pharmaceuticals Inc, a group of peers worth examining would be MCRB, KALV, CTMX, CNAT, and WVE.
• Visit AGIO's SEC page to see the company's official filings. To visit the company's web site, go to www.agios.com.